// App-Quantinova.ai

: Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy

Researchers

Presenter

  • Laura Janke

Principal Investigators

  • Jieun Kim

  • David Jenkins

  • Monique A Payton

  • Mary V Relling

  • Seth E Karol

Medical Centers

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Center for In Vivo Imaging and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN

  • Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Zoledronic acid

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Asparaginase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved